Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 4426
Country/Region: Guyana
Year: 2007
Main Partner: Initiatives Inc.
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $692,929

Funding for Biomedical Prevention: Injection Safety (HMIN): $692,929

The goal of the Guyana Safer Injection Project (GSIP) is to prevent the transmission of HIV and other blood borne disease through accidental needle stick and sharps injuries, thus minimizing risk to the health care worker, waste handler, client and ultimately the community. Protection is increased by the safety of injection practices, the effectiveness of waste management practices, and prescriber use of and client demand for oral substitutes. The project is focused on implementing strategies that support risk minimization and facilitate the sustainability and institutionalization of injection safety practices and policies. Monitoring and evaluation will ensure constant review and analysis of data and revision of strategies to meet project objectives. After reviewing the findings of its demonstration phase, GSIP initiated its expansion phase in September 2005 in regions six and ten and will incrementally expand to all regions. Strategies are based on the analysis of data from national and regional assessments. Nationally, efforts are focused on improving oversight for planning, implementing and monitoring injection safety policies and practices. The National Injection Safety Group (NISG) created by the MOH and headed by NAPS collaborates with GSIP on the formulation and implementation of a national plan and policy. The Injection Safety (IS) Policy has been approved and will be launched and disseminated to facilities in the public and private sectors this year.

GSIP is building regional commitment through Memorandums of Understanding which detail priority performance areas and targets for improvement. The signed documents define roles and responsibilities for all parties. This enabled a group of MOH staff to be supported as trainers of trainers (TOTs), providing a continual source of IS training for all facilities. It further led to strengthening supervisor skill in collecting and using monitoring data to measure adherence to IS standards and provide needed feedback. The MOH trainers will work with the GSIP to reach our year two training target of 200 providers and 160 waste handlers in IS and interpersonal communication. The regions and facilities also committed to providing pre/post-exposure protection through Hepatitis B and tetanus vaccinations and strategic placement of ARVs. Monthly review of progress against MOU targets deepens understanding and management commitment to change.

In project year two, GSIP is working to ensure the continual availability of appropriate technology by importing auto disable (AD) needles for testing in two large outpatient departments, needle removers for use in health centers and small hospitals and safety boxes for sharps disposal in all facility injection sites. Nationally, GSIP is working with MMU to improve the system for importation, forecasting and supply to avoid risky stock-outs; at the facility level, logistics staff are targeted for improving ordering and distribution of imported goods as well as locally purchased waste segregation and protective gear. To ensure future supply, GSIP will provide data to help the regions and facilities plan and budget for local safe injection supplies.

To improve the safety and effectiveness of waste management, the project led a technical subcommittee to develop draft national standards and is currently supporting the development of waste management plans through regional/facility committees, assisting compliance with segregation, handling and transport of medical waste, final disposal and the use of protective gear. Efforts are being made to identify safe final disposal options for medical waste and financial and technical resources to support construction and use.

Behaviour change communication materials and activities are being used to encourage staff compliance with safer practices, PEP procedures and the client's right to choose oral preparations. The BCC component will provide training to help staff use informational materials to change client and staff behaviour. Awareness raising campaigns for communities will be started to reduce demand for injections and advocate for improved waste disposal systems. Additionally, prescribers are being made aware of the need for rational use of injections, emphasizing orals wherever medically appropriate and nurses are being helped to counsel patients to ask their doctors for oral substitutes.

Subpartners Total: $0
John Snow, Inc: NA
Pathfinder International: NA
Academy for Educational Development: NA